It is currently Mon Nov 20, 2017 6:49 pm

News News of Tcelna (Tovaxin)

Site map of Tcelna (Tovaxin) » Forum : Tcelna (Tovaxin)

A board to discuss Tcelna as a treatment for Multiple Sclerosis

Lookee what I got! :-)

Copied from my e-mail!

Dear Jane,

Thank you very much for your e-mail and letters to Opexa. We appreciate all the effort you and the others are doing and have done to support Tovaxin, by word of mouth, over the Internet blogs and by participating in our clinical studies. I have made sure that the others you attempted to reach (Dr. Fox, Dr. McGuire and Donna Rill) have all received your message.

We are committed ...
Read more : Lookee what I got! :-) | Views : 2021 | Replies : 1


How do you feel Tovaxin users???

It's been over a year since I was droped from the Tovaxin study due to safety concerns. So I went to Johns Hopkins to do HiCy and I am 9 months post treatment.

I am hear to ask everybody who is still in the Tovaxin study how are you feeling? Does Tovaxin seem to work? Anybody get any better? How do the MRIs look now?

Basically does it WORK??

Chris..
Read more : How do you feel Tovaxin users??? | Views : 3818 | Replies : 10


Good news????

http://www.businesswire.com/portal/site ... ewsLang=en

Opexa Therapeutics to Present at the Cambria Capital Investor Meeting

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ: OPXA), a company dedicated to the development of patient-specific cellular therapies for the treatment of autoimmune diseases such as multiple sclerosis and diabetes, is scheduled to present at the Cambria Capital Investor Meeting in Salt Lake City on Thursday, April 9, 2009 at 3:45 p.m. MST.

Neil K. Warma, ...
Read more : Good news???? | Views : 1689 | Replies : 0


Yikes and smiles! :-)

Just got back from the post office; got my three letters in the mail and one e-mail to Neil Warma zipped off. I'll let y'all know if/when I hear some somethin'. Hopefully informative.

God bless us one and all! 8O :lol: :D
Read more : Yikes and smiles! :-) | Views : 1977 | Replies : 1


I got a bill for my last study MRI, did you?

The bill is from were I got my last MRI. Seems it's 30 days over due. It is for $1,650! They filed the claim with my study site, and they were in the process of moving, so I will contact the study site tomorrow. I do have legal insurance, but hoping it doesn't come to that. It could just be my study site but I thought I would check here anyway.
Read more : I got a bill for my last study MRI, did you? | Views : 2811 | Replies : 12


Rough draft

Please comment so I can do the necessary editing. After I get your-all's approval, I'll be sending this to Dawn McGuire and Donna Rill of Opexa and Edward Fox of that central TX MS Center. Here goes:

Four months ago, when Opexa Therapeutics pulled the plug on Phase II-B of Tovaxin, a lot of people were shocked and very unhappy. Especially when some of them—us, rather—had, over the course of the study, become cheerleading advocates. ...
Read more : Rough draft | Views : 2539 | Replies : 10


Partnering with MRF

This report is dated last September; should we start pestering MRF for some attention and seeing what they're up to?

http://www.medicalnewstoday.com/articles/120376.php

Opexa Therapeutics And Myelin Repair Foundation Partner On Novel Multiple Sclerosis Research Program

Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company dedicated to the development of patient-specific cellular therapies for the treatment of autoimmune diseases such as multiple sclerosis (MS) and diabetes, announced the establishment of a novel MS research partnership with the Myelin Repair Foundation, ...
Read more : Partnering with MRF | Views : 1808 | Replies : 0


This is for HEC

I will be in Seattle Feb 18-22. I sent you a Private Message but you've not picked it up.

Let me know if are around those days.
Read more : This is for HEC | Views : 1849 | Replies : 1


Opexa Provides Update on Various Corporate Developments

Just old stuff I'm afraid.

THE WOODLANDS, Texas--(BUSINESS WIRE)--Jan 20, 2009 - Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company dedicated to the development of patient-specific cellular therapies for the treatment of autoimmune diseases such as multiple sclerosis (MS) and diabetes, today announced an update on corporate activities. Since providing additional data analysis for its TERMS Phase IIb clinical trial in October, Opexa has been actively engaged in discussions to partner Tovaxin®, its lead therapy and novel ...
Read more : Opexa Provides Update on Various Corporate Developments | Views : 3259 | Replies : 10


Opexa Provides Update on Various Corporate Developments

http://www.businesswire.com/news/opexa/ ... 0006096/en


THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company dedicated to the development of patient-specific cellular therapies for the treatment of autoimmune diseases such as multiple sclerosis (MS) and diabetes, today announced an update on corporate activities. Since providing additional data analysis for its TERMS Phase IIb clinical trial in October, Opexa has been actively engaged in discussions to partner Tovaxin®, its lead therapy and novel ...
Read more : Opexa Provides Update on Various Corporate Developments | Views : 2089 | Replies : 6


 

Login  •  Register


Statistics

Total posts 240838 • Total topics 26336 • Total members 17541


Contact us | Terms of Service